Eli Lilly and Company
ANTI-HUMAN CD19 ANTIBODIES
Last updated:
Abstract:
The present disclosure relates to antibodies that bind human CD19 ("anti-human CD19 antibodies" or "anti-human CD19 antibodies"), compositions comprising such anti-human CD19 antibodies, and methods of using such anti-human CD19 antibodies.
Status:
Application
Type:
Utility
Filling date:
22 Feb 2021
Issue date:
2 Sep 2021